Freestyle XVII: Sam David Phelps
Sam David Phelps is a patient-designer in Doernbecher Freestyle XVII. His designs were released in February 2022.
Author: Cecily Williams
Freestyle XVII: Maylee Phelps
Maylee Phelps is a patient-designer in Doernbecher Freestyle XVII. Her designs were released in February 2022.
Freestyle XVII: Michael Wilson
Michael Wilson is a patient-designer in Doernbecher Freestyle XVII. His designs were released in February 2022.
Freestyle XVII: Cidni O’Brien
Cidni O’Brien is a patient-designer in Doernbecher Freestyle XVII. Her designs were released in February 2022.
Four questions with Pari Faraji, M.D.
Four questions with about child and adolescent psychiatry with Pari Faraji, M.D. the director of the Pediatric Psychosis Clinic at OHSU Doernbecher Children’s Hospital.
Cell researchers awarded $1 million grant from W.M. Keck Foundation
The W. M. Keck Foundation has awarded research duo Catherine Galbraith, Ph.D., and James Galbraith, Ph.D., $1 million over three years to develop a one-of-a-kind imaging and computational system. Their system will seek to decode molecular aggregates — collections of proteins or ribonucleic acid that frequently rearrange inside cells and are involved in cellular information processing.
Bringing visibility to a rare disease
Nevaeh was diagnosed with Alport Syndrome, a rare genetic disorder that causes kidney disease. Hear from Nevaeh about her experience at Doernbecher and her hopes for the future.
Here for you
This holiday season, we celebrate you and the spirit of giving that makes a difference in people’s lives. We’ve gathered a few of the heartwarming, inspiring stories this past year made possible by people like you.
Four questions with Shivaani Kummar, MD, FACP
Dr. Kummar’s work is dedicated to early phase clinical trials — discovering new therapies for cancer and giving more people access to safe, experimental cancer treatments.
Four questions with Mark Pennesi, MD, PhD
Dr. Pennesi led the first-ever CRISPR gene-editing procedure within the human body, which is showing promising results. We asked him four questions about his research and what this breakthrough could mean.
